Rodney McDonald, MD
Family Medicine · Fort Smith, ARNPI 1811945983
Payments from drug & device makers
Across 13 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$50
- Eisai Inc.$38
- Alkermes, Inc.$36
- AbbVie$22
- Mylan Specialty L.p.$22
- Pear Therapeutics (US), Inc.$21
- plus $23 from 2 others
What the payments were for
- Food & beverage$213100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $50 |
| Eisai Inc. | 2 | $38 |
| Alkermes, Inc. | 2 | $36 |
| AbbVie | 1 | $22 |
| Mylan Specialty L.p. | 1 | $22 |
| Pear Therapeutics (US), Inc. | 1 | $21 |
| Pfizer | 1 | $13 |
| Organon | 1 | $10 |
How this compares
$213 in reported general payments places this provider in the 30th percentile of 1,347 family medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 50 | $69,829 |
| TrulicityDulaglutide | 45 | $63,205 |
| OzempicSemaglutide | 18 | $36,873 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $9,745 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $7,271 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 29 | $4,814 |
| Varenicline Tartrate | 15 | $4,062 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $3,586 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 60 | $1,849 |
| Ventolin HfaAlbuterol Sulfate | 29 | $1,570 |
| Omeprazole | 91 | $1,202 |
| Atorvastatin Calcium | 127 | $1,126 |
| Ranolazine ErRanolazine | 12 | $1,051 |
| Diclofenac Sodium | 37 | $681 |
| Fluticasone Propionate | 40 | $642 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Fort Smith
- Glenn GibbonsFort Smith$179K
- Thinh NguyenFort Smith$28K
- Allen BeachyFort Smith$21K
- Michael CallawayFort Smith$15K
- George KonisLittle Rock$26.6M
- Kevin RobertsLittle Rock$2.5M
- Derek LewisLittle Rock$1.7M
- Jodi SansonHot Springs$1.7M
- Senthil RaghavanLittle Rock$496K
- Broderick EatonWynne$442K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.